‌

US Patent 8999967 Tricyclic fused ring inhibitors of hepatitis C

Patent 8999967 was granted and assigned to Presidio Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Leping Li0

Min Zhong0

Date of Patent

April 7, 2015

Patent Application Number

13877151

Date Filed

September 28, 2011

Patent Primary Examiner

Patent abstract

Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 8999967 Tricyclic fused ring inhibitors of hepatitis C

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.